Clinical specimens from Pt1, Pt5 and Pt8 were available, and tumour cells before treatment and at clinical response were sorting-enriched (more than 95%) and analysed for tumour-specific H3K27me3. This evidence concerns the gene ZNF77 and neoplasm.